Single-center phase 2 study of PD-1 inhibitor combined with DNA hypomethylation agent + CAG regimen in patients with relapsed/refractory acute myeloid leukemia
Article in Cancer Immunology, Immunotherapy (May 2023)
The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.
Impact of FLT3-ITD location on cytarabine sensitivity in AML: a network-based approach
Article in Leukemia (March 2023)
Kermanian propolis induces apoptosis through upregulation of Bax/Bcl-2 ratio in acute myeloblastic leukemia cell line (NB4).
Article in Journal of Cancer Research and Therapeutics (January 2023)